Avalon to Release Fourth Quarter and Full Year 2006 Financial Results
March 14 2007 - 10:00AM
PR Newswire (US)
GERMANTOWN, Md., March 14 /PRNewswire-FirstCall/ -- Avalon
Pharmaceuticals, Inc. (NASDAQ:AVRX) today announced that it is
scheduled to release financial results for the fourth quarter and
full year of 2006, on Wednesday, March 21, 2007 after the close of
the U.S. financial markets. The Company will host a conference call
on Thursday, March 22, 2007 at 8:00 a.m. Eastern Time to provide a
company update and discuss the financial results for the quarter
and full year. Interested investors, analysts, members of the media
and the general public can listen to the call live over the
Internet from the investor section of the Company's website or by
dialing the numbers listed below. Conference Call Details:
------------------------ Dial-In: 866.383.8108 (U.S.) 617.597.5343
(International) Passcode: 31676140 Webcast: Please go to
http://www.avalonrx.com/, Investor Relations/ Upcoming
Presentations, within 15 minutes prior to the call and select the
webcast link. The conference call replay will be available through
April 30, 2007 on Avalon's website (http://www.avalonrx.com/).
About Avalon Pharmaceuticals Avalon Pharmaceuticals is a
biopharmaceutical company using its proprietary technology,
AvalonRx(R), to discover and develop cancer therapeutics. Avalon
has a lead product in Phase I clinical development (AVN944 - IMPDH
inhibitor), as well as preclinical programs to discover inhibitors
for the beta-catenin and aurora pathways now in late stage lead
candidate optimization. Avalon also has discovery programs on
modulators of survivin function and a drug discovery program
targeting the MYC oncoprotein, one of the most important and
previously intractable cancer targets. The company has value
generating partnerships with Merck, MedImmune, Medarex and
Novartis. Avalon Pharmaceuticals was established in 1999 and is
headquartered in Germantown, Md. DATASOURCE: Avalon
Pharmaceuticals, Inc. CONTACT: Gary Lessing, Executive Vice
President and CFO of Avalon Pharmaceuticals, Inc., +1-301-556-9900,
Fax +1-301-556-9910, or Web site: http://www.avalonrx.com/
Copyright
Avalon (NASDAQ:AVRX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Avalon (NASDAQ:AVRX)
Historical Stock Chart
From Jul 2023 to Jul 2024